1620 Investment Advisors, Inc. Organon & Co. Transaction History
1620 Investment Advisors, Inc.
- $124 Million
- Q3 2024
A detailed history of 1620 Investment Advisors, Inc. transactions in Organon & Co. stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 75 shares of OGN stock, worth $1,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$1,188
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding OGN
# of Institutions
794Shares Held
202MCall Options Held
1.71MPut Options Held
865K-
Black Rock Inc. New York, NY32.6MShares$516 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$478 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$177 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$155 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$142 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.03B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...